LAZERTINIB MESYLATE | N219008 | JANSSEN BIOTECH INC
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| RE50528Newly listed — daily FDA feed, not yet in monthly Orange Book edition | Oct 13, 2035 | — | Yes | Yes | — | |
| 9593098 | Oct 13, 2035 | — | Yes | Yes | — | |
| 11453656 | Apr 18, 2038 | — | Yes | Yes | — | — |
| 11850248 | Aug 1, 2041 | — | — | — | — | |
| 11879013 | May 21, 2040 | — | — | — | — | |
| 11981659 | Apr 18, 2038 | — | — | — | — | |
| 12138351 | Apr 13, 2041 | — | — | Yes | — | — |
| 12318390 | Apr 18, 2038 | — | — | Yes | — | — |
| 12599606 | May 14, 2040 | — | — | — | — |
| Code | Date | Status |
|---|---|---|
| NCE | Aug 19, 2029 | Active |